Search results
Gilead gives up on $4.9B antibody as solid tumor plan unravels
FierceBiotech· 6 days agoA $4.9 billion hole has appeared in Gilead Sciences' pipeline. After years of setbacks, the Big Biotech dealt a final blow to its anti-CD47 monoclonal antibody< ...
Dengue Fever
Health via Yahoo News· 6 days agoBlood tests can be ordered to rule out other possible illnesses. There are two main types of blood tests used to diagnose dengue: antibody and molecular...
Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Domestic Dairy Cattle...
Centers for Disease Control and Prevention· 8 hours agoAvian Influenza A(H5N1) in Dairy Cattle and Cats
Map reveals 32 states where dog owners warned of common tick-borne disease
Newsweek· 13 hours agoVeterinarians from the Virginia-Maryland College of Veterinary Medicine have warned that the...
Earnings call: Bio-Techne sees growth in Q3 with strong market positioning
Investing.com· 2 hours agoThe company's Diagnostics and Genomics segment showed a robust 10% organic growth, while the Protein...
Cross-Sectional Study of Q Fever Seroprevalence among Blood Donors, Israel, 2021
Centers for Disease Control and Prevention· 5 days agoQ fever, caused by infection with the bacterium Coxeilla burnetii, is an endemic disease in Israel. In 2021, a total of 341 cases of Q fever were reported to the Epidemiology Division, Ministry ...
Drug appears to reverse type 1 diabetes in mice
Futurity· 2 days agoAn experimental monoclonal antibody drug appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals’ lifespan ...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy
Investor's Business Daily· 5 days agoPfizer won FDA approval for a new hemophilia B gene therapy, a rival to Hemgenix from CSL and Uniqure.
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor
FOX 59 Indianapolis· 7 days ago...ASCO) annual meeting, which will be held in Chicago, USA, from May 31-June 4, 2024. 9MW2821 is...
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update
FOX21 Colorado Springs· 2 days agoDelivered solid performance to start 2024, with record-breaking first quarter revenue of 34.1 billion KRW. Phase 3 VELOS-4 study of tanfanercept in dry eye disease expected ...
